News

AddToAny

Google+ Facebook Twitter Twitter

AI can predict Crohn’s disease recurring after surgery

Using an artificial intelligence (AI) tool that emulates how humans visualise and is trained to recognise and classify images, investigators constructed a model that predicts the postoperative recurrence of Crohn’s disease with high accuracy by evaluating histological images.

The AI tool also revealed previously unrecognised differences in adipose cells and significant differences in the extent of mast cell infiltration in the subserosa, or outer lining of the intestine, comparing patients with and without disease recurrence.

The 10-year rate of postoperative symptomatic recurrence of Crohn’s disease, a chronic inflammatory gastrointestinal disease, is estimated at 40%.

There are scoring systems to evaluate Crohn’s disease activity and the existence of postoperative recurrence, but no system had been developed to predict whether Crohn’s disease might recur.

Lead author Takahiro Matsui said: “Most of the analysis of histopathological images using AI in the past have targeted malignant tumours. We aimed to obtain clinically useful information for a wider variety of diseases by analysing histopathology images using AI. We focused on Crohn’s disease, in which postoperative recurrence is a clinical problem.”

Sixty-eight patients with Crohn’s disease who underwent bowel resection were included in the study.

bit.ly/3yxyRfN

 

Image credit | Shutterstock

Related Articles

melanoma cell - CREDIT - science-photolibrary-f0403499

Phenotypic plasticity in melanoma: the impact on management strategies

Dr Ghada Elayat looks at the role of epithelial–mesenchymal transition in cancer and the implications for melanoma development.

A.I., Chat with AI, Artificial Intelligence-CREDIT-iStock-1494073860

AI search engines put to the test

Four proposed state-of-the-art image search engines for automating search and retrieval of digital histopathology slides were found to be of inadequate performance for routine clinical care, US research suggests.

alexandra grainey and team CREDIT_Supplied

My lab: innovative cellular pathology

A guided tour of cellular pathology at One Dorset Pathology.

big question headline

What safeguards and regulations would you like to see in place for AI pathology?

With artificial intelligence (AI) becoming ever more sophisticated and prevalent across society, combined with advances in digital pathology and the fast-paced progress in deep learning, we may be on the cusp of the era of AI in pathology. However, with technical, logistical and ethical barriers in place, we look at what measures are needed before widespread clinical adoption.

Top